+ Reply to Thread
Page 1 of 3 1 2 3 LastLast
Results 1 to 10 of 30
  1. #1
    Senior Member
    Join Date
    Feb 2013
    Posts
    280

    Default Anderans underwhelming?

    Hello all, long time lurker here. I did look at Anderan's most recent presentation last year, and the macro photos they provided are nothing short of underwhelming. What solid evidence is there, if any, that anderans can at least immunize follicles?

  2. #2
    Senior Member
    Join Date
    May 2012
    Posts
    4,423

    Default

    Quote Originally Posted by stayhopeful View Post
    Hello all, long time lurker here. I did look at Anderan's most recent presentation last year, and the macro photos they provided are nothing short of underwhelming. What solid evidence is there, if any, that anderans can at least immunize follicles?
    Its pure speculation for the time being. We'll know more as Aderans comes closer to finishing Phase III trials which should be starting in about a month or so (assuming they start right after all Phase II trials are over, the last one being by April at the latest).

  3. #3
    Senior Member Desmond84's Avatar
    Join Date
    Oct 2012
    Posts
    987

    Default

    DHT immunity is a speculation based on the fact that they are using DP cells which harbour the Androgen receptors!

    We actually should have that question answered by July this year when they announce their final Phase 2 results! Some of their trials did go for 18-24 months so they should have a clear picture of whether their treatment has staying power!

  4. #4
    Senior Member Desmond84's Avatar
    Join Date
    Oct 2012
    Posts
    987

    Default

    If Aderans fails we are in big trouble though! Apart from Histogen there is nothing promising in the near future! Tsuji labs will eventually bring Hair multiplication to market but we could be middle aged men by then!

  5. #5
    Senior Member
    Join Date
    Feb 2013
    Posts
    280

    Default

    It would be ideal if both histogen AND anderans prove to be successful, but just one of them would be a game changer. Does anyone know about this "scarless FUE" the was posted on this forum a month or two ago. Looks very promising. Advanced scarless FUE procedures supplemented by either Anderans or Histogen could make us all look like our 22 year old selves.

    BUT, in any event, should not the picture/outlook for Anderans and Histogen be extremely clear by fall this year??

  6. #6
    Senior Member
    Join Date
    Apr 2012
    Location
    London, UK
    Posts
    605

    Default

    Quote Originally Posted by Desmond84 View Post
    If Aderans fails we are in big trouble though! Apart from Histogen there is nothing promising in the near future! Tsuji labs will eventually bring Hair multiplication to market but we could be middle aged men by then!
    Hey Desmond

    You seemed quite confident that ade rand would release something around 2015. Has your opinion changed. Surely they must be on to something if they are moving on to phase 3

    When I see less than optimistic comments from you I worry!

  7. #7
    Senior Member
    Join Date
    Apr 2012
    Location
    London, UK
    Posts
    605

    Default

    Aderans I mean

    Damn predictive text!

  8. #8
    Senior Member Desmond84's Avatar
    Join Date
    Oct 2012
    Posts
    987

    Default

    Quote Originally Posted by garethbale View Post
    Hey Desmond

    You seemed quite confident that aderans would release something around 2015. Has your opinion changed. Surely they must be on to something if they are moving on to phase 3

    When I see less than optimistic comments from you I worry!
    Aderans is still my only hope! But what UK_Boy is talking about regarding response rate is also true.

    I think Aderans will move to Phase 3 if:

    - A Genetic test to determine whether you're a responder is found! (the next question would be: "would this test require you giving up 1cm2 of your donor area or would a simple mouth swab suffice?"

    - No serious adverse events reported (i.e. cyst formation, ingrown hairs, or even possibly cancer!)

    - DHT resistance for a sustained period of time! Hopefully somewhere around the 10 year mark (if you would require top ups every year that would make this therapy useless as you will eventually deplete all of your donor area by giving up 1cm2 each time)

    Almost all of these questions will be answered this year and we'll be more than likely able to guess whether Aderans will be moving to Phase 3 or not!

    It's going to be a BIG YEAR for hairloss that's for sure. It's going to be make or break for: Aderans, Histogen & Replicel.

    If Aderans can satisfy these 3 criterias then you can be sure it will be on the market sometimes after Q4 2015.

    P.S. Regarding fast-tracking Aderans approval: I have been doing a lot of reading guys and there's gonna be no way FDA would let that happen! There's some potential risks with Aderans which might further delay its FDA approval process; Here's what I found so far:

    "There is a hypothesis that several cancers may arise from stem cells that exist in different tissues. These cancer stem cells are called "side population" (SP) cells and have been identified in: leukemia, breast cancer and several human cancer cell lines (central nervous system, gastrointestinal tumors, retinoblastoma). There is still a "chicken and egg" problem to be resolved, in that the cancer cells may have dedifferentiated to a stem cell-like population."

    So what it means is that they don't know if these side population cells form after introduction of stem cells or if they existed prior to stem cell transplantation!

    This means that FDA will require extensive amount of safety data from Aderans to ensure this therapy is not carcinogenic! Don't forget that this is the first time ever this approach has been tried in medicine to form chimeric organs!

    I think once Phase 3 is completed, we might be looking at 12-18 of FDA Approval process, with FDA constantly requiring further information and explanation from ARI.

  9. #9
    Senior Member Desmond84's Avatar
    Join Date
    Oct 2012
    Posts
    987

    Default

    Now being the first Human Autologous stem cell treatment means that neither FDA nor ARI are 100% sure about what type of safety studies should they be conducting and for how long!

    This lack of knowledge makes FDA even more stringent and cautious in my opinion which might mean they will expect ARI to conduct its Phase 3 trial for longer than 12 months to establish safety!

  10. #10
    Senior Member
    Join Date
    Nov 2012
    Location
    Bahrain
    Posts
    467

    Default

    Desmond84, What if Histogen success and Aderans fails? Will it be a problem to us? I think they are having almost similar roles? Just wondering!!!

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth

» Recent Threads

1800 graft repair case results by Dr. Lindsey
Yesterday 08:38 AM
Last Post By Dr. Lindsey
Yesterday 08:38 AM
Navigating the German Job Market as a Kenyan Citizen
11-04-2023 06:31 AM
Last Post By Keegan212
Yesterday 03:51 AM
DR HAKAN DOGANAY/ 4500 GRAFTS / Implanter Pen+FUE
03-26-2024 04:15 PM
Last Post By Hakan Doganay, MD
03-26-2024 04:15 PM
The Mane Event for Thursday, June 15th, 2023
06-15-2023 02:59 PM
Last Post By gisecit34
03-26-2024 08:05 AM